FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Gilenya 500 microgram capsule
Gilenya 500 microgram capsule, 28, blister pack
Gilenya 500 microgram capsule, 7, blister pack
Hemlibra 105 mg/0.7 mL injection, 0.7 mL vial
Hemlibra 105 mg/0.7 mL injection, 0.7 mL vial
Hemlibra 150 mg/mL injection, vial
Hemlibra 150 mg/mL injection, 1 mL vial
Hemlibra 30 mg/mL injection, vial
Hemlibra 30 mg/mL injection, 1 mL vial
Hemlibra 60 mg/0.4 mL injection, 0.4 mL vial
Hemlibra 60 mg/0.4 mL injection, 0.4 mL vial
Icatibant (Cipla) 30 mg/3 mL injection, 3 mL syringe
Icatibant (Cipla) 30 mg/3 mL injection, 3 mL syringe
Icatibant (Lupin) 30 mg/3 mL injection, 3 mL syringe
Icatibant (Lupin) 30 mg/3 mL injection, 3 mL syringe
Icaticip 30 mg/3 mL injection, 3 mL syringe
Icaticip 30 mg/3 mL injection, 3 mL syringe
Icazyr 30 mg/3 mL injection, 3 mL syringe
Icazyr 30 mg/3 mL injection, 3 mL syringe
Idhifa 100 mg tablet
Idhifa 100 mg tablet, 30, bottle
Idhifa 50 mg tablet
Idhifa 50 mg tablet, 30, bottle
Ikervis 0.1% eye drops, 0.3 mL unit dose
Ikervis 0.1% eye drops, 30 x 0.3 mL unit doses, ampoule
Ilumya 100 mg/mL injection, syringe
Ilumya 100 mg/mL injection, 1 mL syringe
Iluvien 190 microgram implant
Iluvien 190 microgram implant, 1, applicator
Imdevimab (Roche) 120 mg/mL injection, 2.5 mL vial
Imdevimab (Roche) 120 mg/mL injection, 2.5 mL vial
Imdevimab (Roche) Multidose 120 mg/mL injection, 11.1 mL vial
Imdevimab (Roche) Multidose 120 mg/mL injection, 11.1 mL vial
Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial
Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial
Imfinzi 500 mg/10 mL injection, 10 mL vial
Imfinzi 500 mg/10 mL injection, 10 mL vial
Increlex 10 mg/mL injection, 4 mL vial
Increlex 10 mg/mL injection, 4 mL vial
Inovelon 100 mg tablet
Inovelon 100 mg tablet, 10, blister pack
Inovelon 100 mg tablet, 100, blister pack
Inovelon 100 mg tablet, 30, blister pack
Inovelon 100 mg tablet, 50, blister pack
Inovelon 100 mg tablet, 60, blister pack
Inovelon 200 mg tablet
Inovelon 200 mg tablet, 10, blister pack
Inovelon (rufinamide 200 mg) tablet, 100 tablets, blister pack (containered trade product pack)
Inovelon 200 mg tablet, 30, blister pack
Inovelon 200 mg tablet, 50, blister pack
Inovelon 200 mg tablet, 60, blister pack
Inovelon 400 mg tablet
Inovelon 400 mg tablet, 10, blister pack
Inovelon 400 mg tablet, 100, blister pack
Inovelon (rufinamide 400 mg) tablet, 30 tablets, blister pack (containered trade product pack)
Inovelon 400 mg tablet, 50, blister pack
Inovelon 400 mg tablet, 60, blister pack
Inqovi 35/100 tablet
Inqovi 35/100 tablet, 5, blister pack
Inqovi 35/100 tablet, 5, bottle
Isturisa 1 mg tablet
Isturisa 1 mg tablet, 60, blister pack
Isturisa 10 mg tablet
Isturisa 10 mg tablet, 60, blister pack
Isturisa 5 mg tablet
Isturisa 5 mg tablet, 60, blister pack
Jemperli 500 mg/10 mL injection, 10 mL vial
Jemperli 500 mg/10 mL injection, 10 mL vial
Jivi (1 x 1000 units vial, 1 x 2.5 mL inert diluent syringe), 1 pack
Jivi (damoctocog alfa pegol 1000 units) powder for injection, 1000 units vial
Jivi (1 x 2000 units vial, 1 x 2.5 mL inert diluent syringe), 1 pack
Jivi (damoctocog alfa pegol 2000 units) powder for injection, 2000 units vial
Jivi (1 x 250 units vial, 1 x 2.5 mL inert diluent syringe), 1 pack
Jivi (damoctocog alfa pegol 250 units) powder for injection, 250 units vial
Jivi (1 x 3000 units vial, 1 x 2.5 mL inert diluent syringe), 1 pack
Jivi (damoctocog alfa pegol 3000 units) powder for injection, 3000 units vial
Jivi (1 x 500 units vial, 1 x 2.5 mL inert diluent syringe), 1 pack
Jivi (damoctocog alfa pegol 500 units) powder for injection, 500 units vial
Kamrab 1500 units/10 mL injection, 10 mL vial
Kamrab 1500 units/10 mL injection, 10 mL vial
Kamrab 300 units/2 mL injection, 2 mL vial
Kamrab 300 units/2 mL injection, 2 mL vial
Kerendia 10 mg tablet
Kerendia 10 mg tablet, 100, blister pack
Kerendia 10 mg tablet, 14, blister pack
Kerendia 10 mg tablet, 28, blister pack
Kerendia 10 mg tablet, 98, blister pack
Kerendia 20 mg tablet
Kerendia 20 mg tablet, 100, blister pack
Kerendia 20 mg tablet, 14, blister pack
Kerendia 20 mg tablet, 28, blister pack
Kerendia 20 mg tablet, 98, blister pack
Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device
Kesimpta 20 mg/0.4 mL injection, 0.4 mL syringe
Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device
Kesimpta 20 mg/0.4 mL injection, 0.4 mL syringe
Kevzara 150 mg/1.14 mL injection, 1.14 mL pen device
Kevzara 150 mg/1.14 mL injection, 1.14 mL syringe
Kevzara 150 mg/1.14 mL injection, 2 x 1.14 mL pen devices
Kevzara 150 mg/1.14 mL injection, 2 x 1.14 mL syringes
Kevzara 200 mg/1.14 mL injection, 1.14 mL pen device

Start Previous Page 5 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start